We found that the allulose treatment suppressed IFN-γ signaling and improved macrophage dysfunction in the liver and adipose tissue, mitigating obesity-induced chronic inflammation. The gene discussed is IFNG; the disease is obesity due to melanocortin 4 receptor deficiency.